Nigel McCracken, chief operating officer, Virax Biolabs explains how the ViraxImmune PAIS assay uses T cell responses and cytokine levels to detect immune dysfunction and identify viral triggers of ...

Inflammation isn’t always a bad thing, so you don’t want to (and can’t) rid your body of it entirely. It’s actually a normal ...

a 2022 study found that 14% of patients who were diagnosed and treated early with antibiotic therapy would still develop Post ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and ...

New research suggests that lingering cell wall fragments from the Lyme disease bacterium, Borrelia burgdorferi, may be responsible for persistent symptoms long after antibiotic treatment.